Trial intelligence / Profile preview

Pentoxifylline for adhesive capsulitis

IRCT20181103041531N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in adhesive capsulitis (AC) comparing Pentoxifylline with Placebo (2 arms). Primary endpoints: Affected shoulder range of motion and Serum TNF-alpha level. Started Jan 2019; status: completed.

02

Drugs

pentoxifylline
03

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on IRCT20181103041531N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181103041531N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call